medindia
  1. Medindia
  2. Health Tips and Quotations

Health Tip to Prevent Stroke in Atrial Fibrillation

Newer drugs called direct oral anticoagulants which include edoxaban, apixaban, rivaroxaban and dabigatran have been approved by the US Food and Drug Administration (USFDA) for the treatment of non-valvular atrial fibrillation. A review on the use of the drugs for the purpose was published in the US Pharmacist.

Direct Oral Anticoagulants (DOAC) Prevent Stroke in Atrial Fibrillation - Oral anticoagulants are most convenient to take than injectable ones - Available alternatives of warfarin - Edoxaban, Apixaban, Rivaroxaban and DOACs

Direct Oral Anticoagulants (DOAC) in Atrial Fibrillation

The direct oral anticoagulants edoxaban, apixaban, rivaroxaban and dabigatran have been recently approved for the treatment of non-valvular atrial fibrillation. Read More

Related Links

Inactivity is a Silent Risk-Detect It, Defeat It
Avoid Non-Veg Meals on Flights: Here’s Why!
Can Your Hair Products Cause Cancer?
Eat Less, Live More: The Science of Calorie Restriction
Why Tea Makes You Poop: Laxative Effects of Your Morning Brew
Asthma and Diet: Foods That Could Worsen Your Symptoms
Gut-Brain Link: A Game-Changer in Treating Depression
Healthy or Hype: The Reality of Healthy Food
Why Indian Women Are Missing Vitamin D
Role of Vitamin D in Fertility and Pregnancy
Health Benefits of Playing Chess: Boost Your Brain Power
Why Stomach Cancer Rates Are Surging in India and How to Stay Safe

Wildcard SSL

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer

Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025